Is there too much of a conflict of interest between industry and RCTs?
Is the relationship between industry and randomised controlled trials (RCTs) too cosy? Or instead, is it a vital relationship that can help drive improvements...
Spinal News International’s top 10 most popular stories of January 2023
Our most viewed piece in January was an insightful video interview—conducted at DWG Kongress—with Michael Fehlings (Toronto, Canada) on the management of patients with...
Spinal News International’s top 10 most popular stories of December 2022
Some major regulatory announcements took centre stage in our most read articles of December, with the top story revealing that the Swiss Federal Assembly...
Spinal News International’s top 10 most popular stories of November 2022
Taking top spot in our most read Top 10 for November was a comment piece by Brian Fiani (New York, USA), who examined the...
